Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Narrative (Details)

v3.24.1.1.u2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Apr. 14, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Apr. 22, 2022
Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]            
Price per share (in dollars per share)   $ 4.39        
Unused capacity   $ 33,300        
Increase in fair value of private warrant liability   $ 1,075        
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income   Other Nonoperating Income (Expense) Other Nonoperating Income (Expense)      
Fair value, liability, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income   Other Nonoperating Income (Expense) Other Nonoperating Income (Expense)      
Private Warrants            
Subsidiary, Sale of Stock [Line Items]            
Warrants outstanding (in shares)   7,732,168   7,732,168   7,732,168
Number of warrants to purchase common stock (in shares)           1
Fair value (in dollars per share)   $ 0.57   $ 0.43    
Increase in fair value of private warrant liability   $ 1,075 $ 2,800      
Public Warrants            
Subsidiary, Sale of Stock [Line Items]            
Fair value (in dollars per share)           $ 11.50
Committed equity facility            
Subsidiary, Sale of Stock [Line Items]            
Share purchase period 24 months          
Percentage of share issued 19.99%          
Percentage of share eligible to be purchased based on purchase volume reference amount 50.00%          
Trading day period 10 days          
Percentage of share eligible to be purchased based on shares traded 20.00%          
Sale of stock, number of shares authorized for issuance (in shares)         9,000,000  
Beneficial ownership percentage 4.99%          
Sale of stock, amount authorized to issue and sell $ 80,000          
Percentage of purchase price per share 0.97          
Percentage of commission on gross proceeds 3.00%          
Shares from transaction (in shares)   0        
Remaining shares available (in shares)   7,592,939